This article has been retracted: please see Elsevier's Article Correction, Retraction and Removal Policy Article withdrawal | Elsevier policy.

Tai Y-T, Fulciniti M, Hideshima T, Song W, Leiba M, Li X-F, Rumizen M, Burger P, Morrison A, Podar K, Chauhan D, Tassone P, Richardson P, Munshi NC, Ghobrial IM, Anderson KC. Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis. Blood 2007;110(5):1656-1663.

This article has been retracted at the request of the Editors and authors.

Within the paper, image issues were identified in Figures 1, 4, and 6. Images within these figures show duplication, modification, or unmarked splices.

The authors state that these figures cannot be used to support the conclusions of the paper.

Authors Tai, Fulciniti, Song, Li, Morrison, Chauhan, Tassone, Ghobrial, and Anderson approve the retraction. Authors Hideshima, Leiba, Rumizen, Burger, Podar, Richardson, and Munshi did not respond.

This content is only available as a PDF.

Author notes

An Inside Blood analysis of this article appears at the front of this issue.

The online version of this article contains a data supplement.

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734.

2007
Sign in via your Institution